Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TGEN - Targeted Genetics Corporation -- Ignore unavailable to you. Want to Upgrade?

To: john b who wrote (196)	5/27/1999 2:59:00 PM
From: ted	Respond to of 557

john b - the company talks openly of late about partnering discussions with several pharma companies relating to their aav process development. imo, this is where near term value lies with the company. they are also planning to initiate more clinical trials on their cancer therapy in conjunction with chemotherapy. I also suspect they will team up with a larger company to move forward with these. If you got in at $5, it was probably in 3rd quarter '97. I started accumulating shares soon after that point and continue to. My target price is above your entry price.